-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation